Skip to main content
$19.58 $0.23 (1.2%)

11:03 AM EDT on 08/13/20

Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

CAPS Rating: 3 out of 5

Current Price $19.58 Mkt Cap $1.3B
Open $19.35 P/E Ratio 0.00
Prev. Close $19.35 Div. (Yield) $0.00 (0.0%)
Daily Range $19.27 - $19.89 Volume 134,871
52-Wk Range $6.75 - $43.56 Avg. Daily Vol. 828,434

Caps

How do you think NASDAQ:ITCI will perform against the market?

Add Stock to CAPS Watchlist

All Players

40 Outperform
6 Underperform
 

All-Star Players

13 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ITCI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.17)
Submitted January 12, 2016

I like Intra-Cellular's position despite the recent massive pullback. After strong enough phase III data from the first schizophrenia trial to support FDA approval, data from the second phase III trial is expected in mid 2016. The company has also… More

km00nster (23.92)
Submitted September 22, 2015

Ran up to much. HUGE secondary offering on the way. 1/3 of it's market cap. Underwriters have been pumping. Seeing this stock on it's way to a major crash. Short-Term PT of under 30

NASDAQ:ITCI VS S&P 500 (SPY)

NASDAQ:ITCI Summary

Fools bullish on NASDAQ:ITCI are also bullish on:

Fools bearish on NASDAQ:ITCI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ITCI.

Recs

0
Member Avatar odocoileus (53.50) Submitted: 2/2/2020 7:00:11 PM : Outperform Start Price: $12.32 NASDAQ:ITCI Score: +47.63

Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market size or marketing muscle, it's a crapshoot for me whether the drug will take off. So here we are. ITCI has a new class of drug in a huge indication. I'm hanging on expecting big things. Tell me what I'm missing.

Recs

0
Member Avatar wrciii (72.99) Submitted: 1/3/2020 7:36:17 PM : Outperform Start Price: $9.83 NASDAQ:ITCI Score: +86.96

David Haen MF

Recs

0
Member Avatar emtking (61.42) Submitted: 12/13/2019 1:05:50 PM : Outperform Start Price: $12.60 NASDAQ:ITCI Score: +45.40

New drug for bipolar disorder looks as close to a sure thing as there can be going into an FDA decision date of December 278th or sooner, 2019.

Leaderboard

Find the members with the highest scoring picks in ITCI.

Score Leader

baselineace

baselineace (24.20) Score: +371.97

Sometimes you just get lucky?

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. km00nster 23.92 9/21/2015 Underperform 5Y $50.63 -62.30% +71.89% +134.18 1 Comment
Hendrickson71 < 20 1/7/2016 Underperform 3W $48.05 -60.27% +72.47% +132.74 1 Comment
stockgripes 98.62 9/16/2015 Underperform 5Y $45.15 -57.72% +68.68% +126.40 1 Comment
wrciii 72.99 12/9/2019 Outperform NS $9.83 +94.20% +7.25% +86.96 2 Comments
allforone 94.38 7/22/2019 Outperform 1Y $11.45 +66.72% +13.37% +53.35 0 Comment
odocoileus 53.50 12/11/2019 Outperform 5Y $12.32 +54.95% +7.32% +47.63 1 Comment
emtking 61.42 12/13/2019 Outperform 5Y $12.60 +51.51% +6.11% +45.40 1 Comment
Corona20 28.56 5/21/2020 Underperform 5Y $22.87 -16.53% +14.04% +30.57 0 Comment
cubswin08 37.21 12/24/2019 Underperform 5Y $25.48 -25.08% +4.79% +29.87 0 Comment
Dananator < 20 8/7/2020 Outperform 5Y $20.97 -8.94% +0.84% -9.78 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ITCI.